State Medicaid program; requiring coverage of insulin and insulin delivery systems; specifying certain covered system. Effective date. Emergency.

SB 926 requires Oklahoma's Medicaid program to cover insulin and insulin delivery devices (like tubeless wearable pumps) when medically necessary for diabetes management. It specifically mandates coverage for devices that automatically deliver insulin, directly affecting Medicaid enrollees with diabetes who rely on these treatments. The bill directs the Oklahoma Health Care Authority to seek federal approval for implementation and takes effect on July 1, 2025. This policy change ensures Medicaid covers essential diabetes care tools without requiring prior authorization for covered devices.